• Home|
  • Products|
  • Resolax 2
Resolax 2 (Prucalopride 2 mg)
Therapeutic Class: Gastro-Intestinal
Pack Size: Each HDPE bottle of Resolax 2 contains 14’s film-coated tablets (each tablet contains Prucalopride Succinate INN equivalent to Prucalopride 2 mg), a silica gel desiccant and polyester coil with a child-resistant closure.

INDICATIONS AND USE
Resolax is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.
DOSAGE AND ADMINISTRATION
Chronic Constipation
Adults
2 mg once daily with or without food, at any time of the day. Due to the specific mode of action of prucalopride (stimulation of propulsive motility), exceeding the daily dose of 2 mg is not expected to increase efficacy.
Older people
Start with 1 mg once daily; if needed the dose can be increased to 2 mg once daily.
Children
Prucalopride should not be used in children and adolescents younger than 18 years
Renal Impairment
The dose for patients with severe renal impairment (GFR < 30 ml/min/1.73 m2) is 1 mg once daily. No dose adjustment is required for patients with mild to moderate renal impairment.
Hepatic Impairment
Patients with severe hepatic impairment (Child-Pugh class C) start with 1 mg once daily which may be increased to 2 mg if required to improve efficacy and if the 1 mg dose is well tolerated. No dose adjustment is required for patients with mild to moderate hepatic impairment.